As Johnson & Johnson (JNJ) Market Valuation Declined, Lpl Financial LLC Raised Holding by $10.86 Million

August 9, 2018 - By Ash Maslow

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It is positive, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Rocky Mountain Advisers Ltd Limited Liability Company stated it has 2,215 shares. Telemus Limited Liability Company has invested 0.33% of its portfolio in Johnson & Johnson (NYSE:JNJ). Hartline Investment accumulated 1,572 shares or 0.06% of the stock. Guinness Asset owns 105,021 shares for 2.96% of their portfolio. Sprucegrove Inv Mgmt Limited reported 1.42% of its portfolio in Johnson & Johnson (NYSE:JNJ). First Republic Investment Mngmt stated it has 0.97% in Johnson & Johnson (NYSE:JNJ). Capital Invest Serv Of America holds 0.23% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 11,616 shares. Park National Corporation Oh accumulated 2.5% or 335,517 shares. Jefferies Group Ltd Liability Corp has invested 0.02% in Johnson & Johnson (NYSE:JNJ). Timber Creek Capital Management Lc owns 952 shares or 0.08% of their US portfolio. Daniel Devine, a Florida-based fund reported 30,457 shares. Robert Wood Johnson Foundation holds 13.00 million shares or 100% of its portfolio. Summit Group Incorporated Limited Liability Company has invested 0.24% in Johnson & Johnson (NYSE:JNJ). Fiduciary Fincl Service Of The Southwest Tx invested in 0.63% or 16,114 shares. First Retail Bank And Trust Company Of Newtown has invested 1.97% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity.

Lpl Financial Llc increased its stake in Johnson & Johnson (JNJ) by 9.72% based on its latest 2018Q1 regulatory filing with the SEC. Lpl Financial Llc bought 84,855 shares as the company’s stock declined 8.03% with the market. The institutional investor held 957,508 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $122.71 million, up from 872,653 at the end of the previous reported quarter. Lpl Financial Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $351.66 billion market cap company. The stock decreased 0.07% or $0.09 during the last trading session, reaching $131.08. About 1.19M shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since August 9, 2017 and is downtrending. It has underperformed by 17.32% the S&P500.

Lpl Financial Llc, which manages about $36.33 billion US Long portfolio, decreased its stake in Oppenheimer Etf Tr by 505,746 shares to 305,463 shares, valued at $10.72M in 2018Q1, according to the filing. It also reduced its holding in Powershares Etf Tr Ii (SPHD) by 154,734 shares in the quarter, leaving it with 1.60 million shares, and cut its stake in Powershares Etf Tr Ii (PZA).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson – Aristocrat Looks Appealing” on July 22, 2018, also Fool.com with their article: “Better Buy: Johnson & Johnson vs. Pfizer” published on August 02, 2018, Benzinga.com published: “Earnings Preview: Healthcare Giant Johnson & Johnson Set To Report Tuesday Morning” on July 16, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Sell Microsoft And Don’t Look Back” published on August 08, 2018 as well as Benzinga.com‘s news article titled: “Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings” with publication date: July 12, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson \u0026 Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Johnson \u0026 Johnson had 15 analyst reports since February 27, 2018 according to SRatingsIntel. Wells Fargo maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Friday, April 13. Stifel Nicolaus maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with “Hold” rating. Credit Suisse upgraded the stock to “Buy” rating in Thursday, April 12 report. The firm has “Buy” rating given on Friday, March 23 by Jefferies. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Thursday, July 12 by Goldman Sachs. The stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by Citigroup on Tuesday, February 27. The company was maintained on Friday, April 20 by Credit Suisse. The stock of Johnson & Johnson (NYSE:JNJ) has “Equal-Weight” rating given on Tuesday, April 10 by Morgan Stanley. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, February 26. Jefferies has “Buy” rating and $165.0 target.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.